Skip to main content
FEEDBACK PLC logo

FEEDBACK PLC — Investor Relations & Filings

Ticker · FDBK ISIN · GB00BJN59X09 LEI · 213800UGOF2GT2U2RV90 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2022-09-06 Regulatory Filings
Country GB United Kingdom
Listing IL FDBK

About FEEDBACK PLC

https://fbkmed.com/

Feedback PLC is a medical technology company specializing in clinical infrastructure software designed to improve healthcare communication and workflows. Its flagship product, Bleepa®, is a secure digital platform that enables asynchronous collaboration among clinicians. Bleepa provides a unified, patient-centric view of clinical data, including diagnostic-quality medical imaging, test results, and case notes. The platform facilitates secure messaging and virtual discussions for individuals and multi-disciplinary teams (MDTs), allowing for faster decision-making and streamlined referral pathways. By enabling remote and asynchronous case reviews, Bleepa aims to improve care coordination, reduce outpatient appointment requirements, and shorten patient treatment times across public and private healthcare settings.

Recent filings

Filing Released Lang Actions
12 month contract for Sussex CDC pilot extension
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 3346Y' and contains standard regulatory boilerplate language, including references to 'Market Abuse Regulations (EU) No. 596/2014 ("MAR")' and concludes with information about RNS, the news service of the London Stock Exchange, and its role as a Primary Information Provider. The content itself is an announcement regarding a new contract award and business update ('Feedback awarded twelve month contract for pilot extension'). This structure—a brief announcement of material news disseminated via the RNS system—is characteristic of a general regulatory filing or news service release, rather than a comprehensive financial report (like 10-K or IR) or a specific document type like a proxy statement or earnings release. Since it is a general regulatory announcement that doesn't fit the more specific categories (like DIV, DIRS, or ER), the most appropriate fallback category is Regulatory Filings (RNS). The document length (7899 chars) is substantial enough that it is the announcement itself, not just a notice of publication (RPA).
2022-09-06 English
Contract Update
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 8874S' and contains standard regulatory boilerplate language from the London Stock Exchange's news service ('This information is provided by RNS...'). The content itself is a 'Contract Update' announcing a strategic shift away from legacy PACS contracts towards the Bleepa product. This type of announcement, which is a specific operational or strategic update released via an RNS feed, fits best under the general 'Regulatory Filings' category (RNS) as it is not a formal financial report (like 10-K or IR), a specific management change (MANG), or a dividend notice (DIV). Given the source and nature (a formal, non-financial-statement regulatory news service release), RNS is the most appropriate classification.
2022-07-19 English
Year End Trading Update
Earnings Release Classification · 1% confidence The document is titled 'Year End Trading Update' and provides unaudited financial highlights (revenue, cash) and operational updates for the year ended May 31, 2022 (FY22). It explicitly states that full year results are expected in September 2022. This content—a preliminary update on performance before the official annual filing—is characteristic of an Earnings Release (ER), which typically provides key highlights shortly after the period ends. It is not the comprehensive 10-K, nor is it a transcript (CT) or a formal audit report (AR). Since it is an announcement of preliminary financial performance highlights, ER is the most appropriate classification. FY 2022
2022-06-16 English
Trading Update & Director Appointment
Board/Management Information Classification · 1% confidence The document is a formal announcement released via RNS (Regulatory News Service) on June 1, 2022. It contains two primary pieces of information: 1) A Trading Update indicating revenue for the year ended May 31, 2022, is expected to be materially ahead of expectations, and 2) An announcement regarding a Director Appointment (Annemijn Eschauzier) and a Director stepping down (Tim Irish). Since the document announces both a trading update (which is usually an ER or MDA) and a management change (MANG), and it is distributed through the RNS system, it functions as a general regulatory announcement. Given the dual nature and the fact that it is a brief update rather than a full report (like 10-K or IR), it fits best under the general regulatory filing category, RNS, which serves as a fallback for miscellaneous announcements not covered by more specific codes like ER (which usually contains detailed figures) or MANG (which focuses solely on board changes). However, because it explicitly announces a director appointment/departure, MANG is a strong candidate. Because it also contains a trading update, and the MANG definition is strictly about changes in the board, RNS is the most appropriate catch-all for combined announcements distributed via the exchange news service.
2022-06-01 English
Change of Registered Office
Regulatory Filings Classification · 1% confidence The document is very short (3225 characters) and announces two administrative changes: a change of registered office address and the appointment of a new Company Secretary. It is formatted as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the London Stock Exchange. Since this is a specific administrative update that doesn't fit into the defined categories like Director's Dealing (DIRS), Capital Change (SHA), or Dividend Notice (DIV), and it is an official announcement published via the regulatory feed, the most appropriate classification is the general Regulatory Filings category (RNS), as it is a miscellaneous regulatory announcement.
2022-05-12 English
Bleepa wins two NHS Contract Awards
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 0271I' and explicitly states 'This is an RNS Reach announcement.' RNS (Regulatory News Service) announcements are typically short updates disseminated via the London Stock Exchange's system. The content announces contract awards and provides brief business updates, which fits the description of a general regulatory announcement or news release that doesn't fit a more specific financial filing category like 10-K or ER. Since it is explicitly identified as an RNS Reach announcement, and the content is a brief operational update, the most appropriate classification is the general Regulatory Filings category (RNS), as it is a regulatory dissemination mechanism, even if the content itself is non-regulatory news.
2022-04-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.